A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.

During the last decade, episodes of sepsis have increased and Escherichia coli has remained the most frequent clinical isolate. Lipopolysaccharides (LPS; endotoxin) are the major toxic and antigenic components of gram-negative bacteria and qualify as targets for therapeutic interventions. Molecules...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Di Padova, F E, Brade, H, Barclay, G R, Poxton, I R, Liehl, E, Schuetze, E, Kocher, H P, Ramsay, G, Schreier, M H, McClelland, D B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC281087/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8359907/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.61.9.3863-3872.1993
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!